JP2007502283A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502283A5
JP2007502283A5 JP2006523322A JP2006523322A JP2007502283A5 JP 2007502283 A5 JP2007502283 A5 JP 2007502283A5 JP 2006523322 A JP2006523322 A JP 2006523322A JP 2006523322 A JP2006523322 A JP 2006523322A JP 2007502283 A5 JP2007502283 A5 JP 2007502283A5
Authority
JP
Japan
Prior art keywords
group
alkyl
cycloalkyl
aryl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006523322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502283A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/025970 external-priority patent/WO2005019240A2/en
Publication of JP2007502283A publication Critical patent/JP2007502283A/ja
Publication of JP2007502283A5 publication Critical patent/JP2007502283A5/ja
Withdrawn legal-status Critical Current

Links

JP2006523322A 2003-08-13 2004-08-11 メラニン凝集ホルモン受容体アンタゴニスト Withdrawn JP2007502283A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49485503P 2003-08-13 2003-08-13
PCT/US2004/025970 WO2005019240A2 (en) 2003-08-13 2004-08-11 Melanin concentrating hormone receptor antagonists

Publications (2)

Publication Number Publication Date
JP2007502283A JP2007502283A (ja) 2007-02-08
JP2007502283A5 true JP2007502283A5 (enExample) 2007-06-28

Family

ID=34215905

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523322A Withdrawn JP2007502283A (ja) 2003-08-13 2004-08-11 メラニン凝集ホルモン受容体アンタゴニスト

Country Status (7)

Country Link
US (1) US20050256161A1 (enExample)
EP (1) EP1654225A4 (enExample)
JP (1) JP2007502283A (enExample)
AU (1) AU2004266228A1 (enExample)
CA (1) CA2534428A1 (enExample)
MX (1) MXPA06001638A (enExample)
WO (1) WO2005019240A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004265189B2 (en) 2003-08-15 2010-03-04 Banyu Pharmaceutical Co., Ltd. Imidazopyridine derivatives
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
ATE499370T1 (de) * 2005-01-19 2011-03-15 Bristol Myers Squibb Co 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3- aminderivate und verwandte verbindungen als p2y1- rezeptor-hemmer zur behandlung thromboembolischer erkrankungen
AU2006232871B9 (en) * 2005-04-01 2011-11-24 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
US7714002B2 (en) * 2005-06-27 2010-05-11 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7816382B2 (en) * 2005-06-27 2010-10-19 Bristol-Myers Squibb Company Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition
WO2007002635A2 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
US7728008B2 (en) * 2005-06-27 2010-06-01 Bristol-Myers Squibb Company N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
JP4870163B2 (ja) 2005-09-30 2012-02-08 エフ.ホフマン−ラ ロシュ アーゲー Mch受容体アンタゴニストとしてのインダン誘導体
RU2009108280A (ru) 2006-08-08 2010-09-20 Санофи-Авентис (Fr) Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение
US7960569B2 (en) * 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
EP2310372B1 (en) 2008-07-09 2012-05-23 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
TW201035088A (en) 2009-02-27 2010-10-01 Supergen Inc Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
MX2012001729A (es) 2009-08-26 2012-06-13 Sanofi Sa Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
RU2013126657A (ru) 2010-11-15 2014-12-27 Эббви Инк. Ингибиторы nampt и rock
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683703B1 (de) 2011-03-08 2015-05-27 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683702B1 (de) 2011-03-08 2014-12-24 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683698B1 (de) 2011-03-08 2017-10-04 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8846666B2 (en) 2011-03-08 2014-09-30 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
HU230880B1 (hu) 2015-04-15 2018-11-29 Richter Gedeon Nyrt Indol származékok
NZ734919A (en) * 2015-04-17 2019-02-22 Dow Agrosciences Llc Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
CN107949279A (zh) 2015-07-06 2018-04-20 得克萨斯系统大学评议会 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
EP3964495A1 (en) * 2016-10-12 2022-03-09 Dow AgroSciences LLC Molecules having pesticidal utility, and compositions, and processes, related thereto

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2730174C2 (de) * 1977-07-04 1981-12-10 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Aminobenzoesäurederivate und Arzneimittel enthaltend solche Aminobenzoesäurederivate
EP0127124A3 (en) * 1983-05-23 1987-04-08 Usv Pharmaceutical Corporation Compounds for treating hypertension
GB0001447D0 (en) * 2000-01-21 2000-03-08 Novartis Ag Organic compounds
HUP0302582A2 (hu) * 2000-12-22 2003-12-29 Schering Corp. Piperidin MCH antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk elhízás kezelésére
DE10123958A1 (de) * 2001-05-17 2002-11-28 Aventis Pharma Gmbh Verfahren zur Identifizierung von Liganden für G protein coupled receptors
PE20021091A1 (es) * 2001-05-25 2003-02-04 Aventis Pharma Gmbh Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
US6552188B2 (en) * 2001-06-29 2003-04-22 Kowa Co., Ltd. Unsymmetrical cyclic diamine compound
DE10139416A1 (de) * 2001-08-17 2003-03-06 Aventis Pharma Gmbh Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2002352878B2 (en) * 2001-11-27 2007-11-22 Merck Sharp & Dohme Corp. 2-Aminoquinoline compounds
US6818772B2 (en) * 2002-02-22 2004-11-16 Abbott Laboratories Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
AU2003226928A1 (en) * 2002-04-09 2003-10-27 7Tm Pharma A/S Novel aminotetraline compounds for use in mch receptor related disorders
WO2003087044A2 (en) * 2002-04-09 2003-10-23 7Tm Pharma A/S Novel carboxamide compounds for use in mch receptor related disorders
US7078430B2 (en) * 2002-07-08 2006-07-18 Ranbaxy Laboratories Limited HMG CoA-reductase inhibitors
FR2842524B1 (fr) * 2002-07-16 2005-04-22 Aventis Pharma Sa Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments
US7091235B2 (en) * 2002-10-15 2006-08-15 Signal Pharmaceuticals, Llc Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer

Similar Documents

Publication Publication Date Title
JP2007502283A5 (enExample)
JP6193922B2 (ja) ハロアルキルヘテロアリールベンズアミド化合物
ES2873949T3 (es) Moduladores del receptor de glucocorticoides de azadecalina condensada con heteroaril-cetona
TW444013B (en) Quinoline and quinazoline compounds useful in treating benign prostatic hyperplasia
RU2010129724A (ru) 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение
JP4294960B2 (ja) 抗癌剤としてのサイクリン依存性キナーゼ阻害剤
RU2007111711A (ru) Производные трициклического лактама в качестве ингибиторов 11-бэта-гидроксистероидной дегидрогеназы
JP2008511683A5 (enExample)
DE69208263T2 (de) Substituierte aminopyrimidine als angiotensin ii antagonisten
RU2009113585A (ru) Производные дибензофурана в качестве ингибиторов pde-4 и pde-10
JP2007502287A5 (enExample)
JP2010513322A5 (enExample)
JP2016053078A (ja) がん及び非新生物性状態の治療方法
JP2017533968A5 (enExample)
JP2013542996A5 (enExample)
ZA200603474B (en) Alkoxy substituted imidazoquinolines
JP2010502689A5 (enExample)
JP2011507878A5 (enExample)
RU2010147404A (ru) Замещенные дигидропиразолоны в качестве ингибиторов hif-пролил-4-гидроксилазы
JP2007530601A5 (enExample)
JP2972377B2 (ja) カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物
JP2011507879A5 (enExample)
AU2015346413A1 (en) Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
JP2020500866A5 (enExample)
JP2005506982A5 (enExample)